Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 8

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Mechanisms of action and clinical effectiveness of herbal treatments for disorders of gut-brain interaction

Moniruzzaman, Md, Shah, Ayesha, Morrison, Mark, Koloski, Natasha, Gwee, Kok Ann, Chen, Minhu, Kim, YongSung, Ayaki, Kana, Efferth, Thomas, Holtmann, Gerald·2025·Digestive and Liver Disease
DOI 10.1016/j.dld.2025.07.010
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dld.2025.07.010

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 182

  1. Sperber, 2021, Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study, Gastroenterology, 160, 99, 10.1053/j.gastro.2020.04.014 · DOI · Paper page
  2. Enck, 2017, Functional dyspepsia, Nat Rev Dis Primers, 3, 10.1038/nrdp.2017.81 · DOI
  3. Black, 2022, British society of gastroenterology guidelines on the management of functional dyspepsia, Gut, 71, 1697, 10.1136/gutjnl-2022-327737 · DOI
  4. Jones, 2023, Placebo effects in functional dyspepsia: causes and implications for clinical trials, Neurogastroenterol Motil, 35, 10.1111/nmo.14527 · DOI
  5. Madisch, 2004, Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial, Digestion, 69, 45, 10.1159/000076546 · DOI
  6. Jung, 2016, Efficacy of DA-9701 (Motilitone) in functional dyspepsia compared to pantoprazole: a multicenter, randomized, double-blind, non-inferiority study, J Neurogastroenterol Motil, 22, 254, 10.5056/jnm15178 · DOI
  7. Suzuki, 2014, Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia–a multicenter, double-blind, randomized, placebo-controlled study, Neurogastroenterol Motil, 26, 950, 10.1111/nmo.12348 · DOI
  8. Liu, 1997, Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial, J Gastroenterol, 32, 765, 10.1007/BF02936952 · DOI · Paper page
  9. Holtmann, 2003, Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial, Aliment Pharmacol Ther, 18, 1099, 10.1046/j.1365-2036.2003.01767.x · DOI · Paper page
  10. Wen, 2019, Effect of Zhizhu Kuanzhong capsules on treatment of functional dyspepsia: a meta-analysis of randomized controlled trials, Chin J Integr Med, 25, 625, 10.1007/s11655-018-2846-0 · DOI
  11. Kim, 2020, Herbal therapies in functional gastrointestinal disorders: a narrative review and clinical implication, Front Psychiatry, 11, 601, 10.3389/fpsyt.2020.00601 · DOI
  12. Grundmann, 2014, Complementary and alternative medicines in irritable bowel syndrome: an integrative view, World J Gastroenterol, 20, 346, 10.3748/wjg.v20.i2.346 · DOI
  13. Drossman, 2016, Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV, Gastroenterology, 10.1053/j.gastro.2016.02.032 · DOI
  14. Holtmann, 2016, Pathophysiology of irritable bowel syndrome, Lancet Gastroenterol Hepatol, 1, 133, 10.1016/S2468-1253(16)30023-1 · DOI · Paper page
  15. Naeye, 1976, Brain-stem and adrenal abnormalities in the sudden-infant-death syndrome, Am J Clin Pathol, 66, 526, 10.1093/ajcp/66.3.526 · DOI
  16. Shah, 2022, The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity, Gut Microbes, 14, 10.1080/19490976.2022.2132078 · DOI
  17. Shanahan, 2023, Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia, Gut, 72, 929, 10.1136/gutjnl-2021-326158 · DOI
  18. Zhong, 2017, Dyspepsia and the microbiome: time to focus on the small intestine, Gut, 66, 1168, 10.1136/gutjnl-2016-312574 · DOI · Paper page
  19. Fairlie, 2023, Overlap of disorders of gut-brain interaction: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol, 8, 646, 10.1016/S2468-1253(23)00102-4 · DOI
  20. Futagami, 2015, Systematic review with meta-analysis: post-infectious functional dyspepsia, Aliment Pharmacol Ther, 41, 177, 10.1111/apt.13006 · DOI
  21. Schwille-Kiuntke, 2015, Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers' diarrhoea, Aliment Pharmacol Ther, 41, 1029, 10.1111/apt.13199 · DOI
  22. Shah, 2022, Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies, Clin Gastroenterol Hepatol, 20, 2229, 10.1016/j.cgh.2022.01.014 · DOI
  23. Burns, 2019, Immune activation in functional gastrointestinal disorders, Gastroenterol Hepatol, 15, 539
  24. Holtmann, 2015, Herbal medicines for the treatment of functional and inflammatory bowel disorders, Clin Gastroenterol Hepatol, 13, 422, 10.1016/j.cgh.2014.03.014 · DOI
  25. Pérez-Burillo, 2020, Plant extracts as natural modulators of gut microbiota community structure and functionality, Heliyon, 6, 10.1016/j.heliyon.2020.e05474 · DOI
  26. Makhoba, 2020, Potential impact of the multi-target drug approach in the treatment of some complex diseases, Drug Dev Ther, 14, 3235, 10.2147/DDDT.S257494 · DOI
  27. Ried, 2020, Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders, Nutr Res, 76, 37, 10.1016/j.nutres.2020.02.008 · DOI
  28. Madisch, 2023, Menthacarin, a proprietary peppermint oil and caraway oil combination, improves multiple complaints in patients with functional gastrointestinal disorders: a systematic review and meta-analysis, Dig Dis, 41, 522, 10.1159/000528553 · DOI
  29. May, 2000, Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia, Aliment Pharm Ther, 14, 1671, 10.1046/j.1365-2036.2000.00873.x · DOI
  30. Heghes, 2019, Antispasmodic effect of essential oils and their constituents: a review, Molecules, 24
  31. Abdi, 2024, Efficacy and safety of alpha-pinene capsule in the management of functional dyspepsia and eradication of helicobacter pylori: a randomized clinical trial, Gastroenterol Hepatol Bed Bench, 17, 140
  32. Golkar, 2019, Essential oil composition, bioactive compounds, and antioxidant activities in Iberis amara L, Nat Prod Commun, 14
  33. Souza, 2011, Gastroprotective activity of alpha-terpineol in two experimental models of gastric ulcer in rats, Daru, 19, 277
  34. da Silva, 2016, alpha-terpineol induces gastric retention of liquids by inhibiting vagal parasympathetic pathways in rats, Planta Med, 82, 1329, 10.1055/s-0042-104657 · DOI
  35. Paula-Freire, 2014, The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice, Phytomedicine, 21, 356, 10.1016/j.phymed.2013.08.006 · DOI
  36. Kowalewski, 1971, Flavonoid compounds in the blossoms of Iberis amara L, Planta Med, 20, 328, 10.1055/s-0028-1099712 · DOI
  37. Kroll, 2009, Kaempferol-3,4′-di-O-beta-glucopyranoside-7-O-alpha-rhamnopyranoside as a new flavonoid from Iberis amara L, Pharmazie, 64, 142
  38. Sibaev, 2010, Iberis amara L. constituents reduce excitatory cholinergic and inhibitory purinergic neurotransmission, Planta Med, 76, 1351, 10.1055/s-0030-1264916 · DOI
  39. Bartlet, 2004, Orientation and feeding responses of the pollen beetle, Meligethes aeneus, to candytuft, Iberis amara, J Chem Ecol, 30, 913, 10.1023/B:JOEC.0000028458.66738.e1 · DOI
  40. Zhai, 2023, Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome, J Pharm Pharm Sci, 26, 10.3389/jpps.2023.11225 · DOI
  41. Lee, 2012, Inhibitory effect of beta-sitosterol on TNBS-induced colitis in mice, Planta Med, 78, 896, 10.1055/s-0031-1298486 · DOI
  42. Agah, 2013, Cumin extract for symptom control in patients with irritable bowel syndrome: a case series, Middle East J Dig Dis, 5, 217
  43. Dosoky, 2018, Chemical composition and biological activities of essential oils of curcuma species, Nutrients, 10, 10.3390/nu10091196 · DOI
  44. Panahi, 2021, Effect of curcumin on severity of functional dyspepsia: a triple blinded clinical trial, Adv Exp Med Biol, 1308, 119, 10.1007/978-3-030-64872-5_10 · DOI · Paper page
  45. Kongkam, 2023, Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial, BMJ Evid Based Med, 28, 399, 10.1136/bmjebm-2022-112231 · DOI
  46. Garabadu, 2015, Protective effect of eugenol against restraint stress-induced gastrointestinal dysfunction: potential use in irritable bowel syndrome, Pharm Biol, 53, 968, 10.3109/13880209.2014.950674 · DOI
  47. Santin, 2011, Gastroprotective activity of essential oil of the syzygium aromaticum and its major component eugenol in different animal models, Naunyn Schmiedeb Arch Pharmacol, 383, 149, 10.1007/s00210-010-0582-x · DOI
  48. Ricci, 2022, Geraniol treatment for irritable bowel syndrome: a double-blind randomized clinical trial, Nutrients, 14
  49. Rizzello, 2018, Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study, BMC Complement Altern Med, 18, 338, 10.1186/s12906-018-2403-6 · DOI
  50. Yeh, 2014, Bioactive components analysis of two various gingers (roscoe) and antioxidant effect of ginger extracts, LWT-Food Sci Technol, 55, 329, 10.1016/j.lwt.2013.08.003 · DOI
  51. Ivashkin, 2022, Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial, PLoS One, 17, 10.1371/journal.pone.0263880 · DOI
  52. Jin, 2014, Ginger and its pungent constituents non-competitively inhibit serotonin currents on visceral afferent neurons, Korean J Physiol Pharmacol, 18, 149, 10.4196/kjpp.2014.18.2.149 · DOI
  53. Liu, 2023, Characteristics of ginsenoside Rd-induced effects on rat intestinal contractility with irritable bowel syndrome, Nat Prod Res, 37, 3152, 10.1080/14786419.2022.2146686 · DOI
  54. Asha, 2013, In vitro anti-helicobacter pylori activity of a flavonoid rich extract of glycyrrhiza glabra and its probable mechanisms of action, J Ethnopharmacol, 145, 581, 10.1016/j.jep.2012.11.033 · DOI
  55. Krausse, 2004, In vitro anti-helicobacter pylori activity of extractum liquiritiae, glycyrrhizin and its metabolites, J Antimicrob Chemother, 54, 243, 10.1093/jac/dkh287 · DOI
  56. Yang, 2013, Chemical composition, antioxidant and antibacterial activities of essential oil from Korean Citrus unshiu peel, J Agric Chem Env, 2, 42
  57. Rombola, 2022, Antispasmodic effect of bergamot essential oil on rat isolated gut tissues, Pharmaceutics, 14
  58. Peana, 2003, (-)-Linalool produces antinociception in two experimental models of pain, Eur J Pharmacol, 460, 37, 10.1016/S0014-2999(02)02856-X · DOI
  59. Santos, 2023, Hypokinetic activity of menthofuran on the gastrointestinal tract in rodents, Evid Based Complement Altern Med, 2023, 10.1155/2023/2726794 · DOI
  60. Chey, 2019, A novel, duodenal-release formulation of a combination of Caraway oil and L-menthol for the treatment of functional dyspepsia: a randomized controlled trial, Clin Transl Gastroenterol, 10, 10.14309/ctg.0000000000000021 · DOI
  61. Lacy, 2022, A novel duodenal-release formulation of caraway oil and L-menthol is a safe, effective and well tolerated therapy for functional dyspepsia, BMC Gastroenterol, 22, 10.1186/s12876-022-02181-5 · DOI
  62. Walstab, 2014, Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders, Neurogastroenterol Motil, 26, 810, 10.1111/nmo.12334 · DOI
  63. Pan, 2012, Central mechanisms of menthol-induced analgesia, J Pharmacol Exp Ther, 343, 661, 10.1124/jpet.112.196717 · DOI
  64. Klopell, 2007, Nerolidol, an antiulcer constituent from the essential oil of Baccharis dracunculifolia DC (Asteraceae), Z Naturforsch C J Biosci, 62, 537, 10.1515/znc-2007-7-812 · DOI
  65. Kim, 2005, Effect of ginseng saponins on a rat visceral hypersensitivity model, Biol Pharm Bull, 28, 2120, 10.1248/bpb.28.2120 · DOI
  66. Wang, 2010, Simultaneous determination of six phenolic compounds in Jujube by LC-ECD, Chromatographia, 71, 703, 10.1365/s10337-010-1485-1 · DOI
  67. Miean, 2001, Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants, J Agric Food Chem, 49, 3106, 10.1021/jf000892m · DOI · Paper page
  68. Liu, 2021, The potential of quercetin to protect against loperamide-induced constipation in rats, Food Sci Nutr, 9, 3297, 10.1002/fsn3.2296 · DOI
  69. Qin, 2019, Quercetin attenuates visceral hypersensitivity and 5-hydroxytryptamine availability in postinflammatory irritable bowel syndrome rats: role of enterochromaffin cells in the colon, J Med Food, 22, 663, 10.1089/jmf.2018.4264 · DOI · Paper page
  70. Modzelewska, 2021, Quercetin relaxes human gastric smooth muscles directly through ATP-sensitive potassium channels and not depending on the nitric oxide pathway, Neurogastroenterol Motil, 33, 10.1111/nmo.14093 · DOI
  71. Iwami, 2011, Inhibitory effects of zingerone, a pungent component of zingiber officinale roscoe, on colonic motility in rats, J Nat Med, 65, 89, 10.1007/s11418-010-0463-0 · DOI
  72. Abdel-Aziz, 2006, Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum, Eur J Pharmacol, 530, 136, 10.1016/j.ejphar.2005.10.049 · DOI
  73. Panahi, 2015, Efficacy and safety of Aloe vera syrup for the treatment of gastroesophageal reflux disease: a pilot randomized positive-controlled trial, J Tradit Chin Med, 35, 632, 10.1016/S0254-6272(15)30151-5 · DOI
  74. Enayati, 2023, The effect of curcumin on the gut-brain axis: therapeutic implications, J Neurogastroenterol Motil, 29, 409, 10.5056/jnm23065 · DOI
  75. Bundy, 2004, Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study, J Altern Complement Med, 10, 1015, 10.1089/acm.2004.10.1015 · DOI · Paper page
  76. Cappello, 2007, Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial, Dig Liver Dis, 39, 530, 10.1016/j.dld.2007.02.006 · DOI · Paper page
  77. Matsueda, 2024, Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study, Biopsychosoc Med, 18, 3, 10.1186/s13030-024-00302-y · DOI · Paper page
  78. Merat, 2010, The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome, Dig Dis Sci, 55, 1385, 10.1007/s10620-009-0854-9 · DOI · Paper page
  79. Nee, 2021, Peppermint oil treatment for irritable bowel syndrome: a randomized placebo-controlled trial, Am J Gastroenterol, 116, 2279, 10.14309/ajg.0000000000001395 · DOI
  80. Ingrosso, 2022, Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome, Aliment Pharmacol Ther, 56, 932, 10.1111/apt.17179 · DOI · Paper page
  81. Alammar, 2019, The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data, BMC Complement Altern Med, 19, 21, 10.1186/s12906-018-2409-0 · DOI · Paper page
  82. Madisch, 1999, Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride - a multicenter, reference-controlled double-blind equivalence study, Arzneim-Forsch-Drug Res, 49, 925
  83. Rich, 2017, A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia, Neurogastroenterol Motil, 29, 10.1111/nmo.13132 · DOI
  84. May, 2003, Peppermint oil and caraway oil in functional dyspepsia–efficacy unaffected by H. pylori, Aliment Pharmacol Ther, 17, 975, 10.1046/j.1365-2036.2003.01522.x · DOI
  85. Gwee, 2023, Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms, J Gastroenterol Hepatol, 38, 197, 10.1111/jgh.16046 · DOI
  86. Zhang, 2021, Menthacarin induces calcium ion influx in sensory neurons, macrophages and colonic organoids of mice, Life Sci, 264, 10.1016/j.lfs.2020.118682 · DOI · Paper page
  87. Oz, 2017, Cellular and molecular targets of menthol actions, Front Pharmacol, 8, 472, 10.3389/fphar.2017.00472 · DOI · Paper page
  88. Haeseler, 2002, Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol, Eur J Anaesthesiol, 19, 571, 10.1097/00003643-200208000-00005 · DOI · Paper page
  89. Thapa, 2022, Peppermint oil effects on the gut microbiome in children with functional abdominal pain, Clin Transl Sci, 15, 1036, 10.1111/cts.13224 · DOI · Paper page
  90. Lluansi, 2024, Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: a pilot study, PLoS One, 19, 10.1371/journal.pone.0297836 · DOI
  91. Landau, 2012, Effects of subinhibitory concentrations of menthol on adaptation, morphological, and gene expression changes in enterohemorrhagic Escherichia coli, Appl Env Microbiol, 78, 5361, 10.1128/AEM.00894-12 · DOI
  92. Hong, 2018, Is effective and safe in short-term treatment of irritable bowel syndrome: a systematic review and meta-analysis, J Neurogastroenterol Motil, 24, 528, 10.5056/jnm18077 · DOI · Paper page
  93. Cellini, 2014, In vitro activity of aloe vera inner gel against Helicobacter pylori strains, Lett Appl Microbiol, 59, 43, 10.1111/lam.12241 · DOI
  94. Ferro, 2003, In vitro susceptibilities of shigella flexneri and streptococcus pyogenes to inner gel of aloe barbadensis miller, Antimicrob Agents Chemother, 47, 1137, 10.1128/AAC.47.3.1137-1139.2003 · DOI
  95. Shilpakala, 2009, Susceptibilities of Escherichia coli and Staphylococcus aureus to Aloe barbadensis, Eur Rev Med Pharmacol Sci, 13, 461
  96. Pandey, 2010, Antibacterial activities of crude extract of Aloe barbadensis to clinically isolated bacterial pathogens, Appl Biochem Biotechnol, 160, 1356, 10.1007/s12010-009-8577-0 · DOI
  97. Tziatzios, 2021, High prevalence of small intestinal bacterial overgrowth among functional dyspepsia patients, Dig Dis, 39, 382, 10.1159/000511944 · DOI
  98. Pistiki, 2014, In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth, Int J Antimicrob Agents, 43, 236, 10.1016/j.ijantimicag.2013.12.008 · DOI
  99. Shah, 2022, Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia, Dig Dis Sci, 67, 2299, 10.1007/s10620-021-07149-1 · DOI
  100. Werawatganon, 2014, Aloe vera attenuated gastric injury on indomethacin-induced gastropathy in rats, World J Gastroenterol, 20, 18330, 10.3748/wjg.v20.i48.18330 · DOI
  101. Naini, 2021, Anti-inflammatory, antioxidant, and healing-promoting effects of aloe vera extract in the experimental colitis in rats, Evid Based Complement Altern Med, 2021, 10.1155/2021/9945244 · DOI
  102. Le Phan, 2021, The role of processed aloe vera gel in intestinal tight junction: an in vivo and in vitro study, Int J Mol Sci, 22, 10.3390/ijms22126515 · DOI
  103. Tandur, 2022, Preclinical studies to evaluate the gut stimulatory activity of aloe Musabbar, Evid Based Complement Altern Med, 2022, 10.1155/2022/4163008 · DOI
  104. Linde, 2008, John's wort for major depression, Cochrane Database Syst Rev, 10.1002/14651858.CD000448.pub3 · DOI · Paper page
  105. Knowles, 2023, The epidemiology and psychological comorbidity of disorders of gut-brain interaction in Australia: results from the Rome foundation global epidemiology study, Neurogastroenterol Motil, 35, 10.1111/nmo.14594 · DOI
  106. Wan, 2010, Effects of antidepressive treatment of Saint John's wort extract related to autonomic nervous function in women with irritable bowel syndrome, Int J Psychiatry Med, 40, 45, 10.2190/PM.40.1.d · DOI · Paper page
  107. Kraft, 1997, Artichoke leaf extract - recent findings reflecting effects on lipid metabolism, liver and gastrointestinal tracts, Phytomedicine, 4, 369, 10.1016/S0944-7113(97)80049-9 · DOI
  108. Walker, 2001, Artichoke leaf extract reduces symptoms of irritable bowel syndrome in a post-marketing surveillance study, Phytother Res, 15, 58, 10.1002/1099-1573(200102)15:1<58::AID-PTR805>3.0.CO;2-R · DOI
  109. Lazzini, 2016, The effect of ginger (Zingiber officinalis) and artichoke (Cynara cardunculus) extract supplementation on gastric motility: a pilot randomized study in healthy volunteers, Eur Rev Med Pharmacol Sci, 20, 146
  110. Van den Abbeele, 2020, In vitro evaluation of prebiotic properties of a commercial artichoke inflorescence extract revealed bifidogenic effects, Nutrients, 12, 10.3390/nu12061552 · DOI
  111. Holgado, 2022, Assessment of the prebiotic potential of globe artichoke by-product through fermentation by human faecal microbiota, Bioact Carb Diet Fib, 28
  112. Lewis, 2020, Efficacy of Lactobacillus paracasei HA-196 and bifidobacterium longum R0175 in alleviating symptoms of irritable bowel syndrome (IBS): a randomized, placebo-controlled study, Nutrients, 12, 10.3390/nu12041159 · DOI
  113. Zhu, 2004, Phenolic compounds from the leaf extract of artichoke (L.) and their antimicrobial activities, J Agr Food Chem, 52, 7272, 10.1021/jf0490192 · DOI
  114. Sabater, 2019, Intestinal anti-inflammatory effects of artichoke pectin and modified pectin fractions in the dextran sulfate sodium model of mice colitis. Artificial neural network modelling of inflammatory markers, Food Funct, 10, 7793, 10.1039/C9FO02221J · DOI
  115. Yongwatana, 2022, Curcuma longa Linn versus omeprazole in treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled trial, J Gastroenterol Hepatol, 37, 335, 10.1111/jgh.15705 · DOI
  116. Peterson, 2018, Effects of turmeric and curcumin dietary supplementation on Human gut microbiota: a double-blind, randomized, placebo-controlled pilot study, J Evid Based Integr Med, 23, 10.1177/2515690X18790725 · DOI
  117. McFadden, 2015, The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention, Inflamm Bowel Dis, 21, 2483, 10.1097/MIB.0000000000000522 · DOI
  118. Goll, 2020, Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome, Gut Microbes, 12, 10.1080/19490976.2020.1794263 · DOI
  119. Bereswill, 2010, Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation, Plos One, 5, 10.1371/journal.pone.0015099 · DOI · Paper page
  120. Ashrafizadeh, 2020, Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury, Curr Mol Med, 20, 116
  121. Hu, 2023, Curcumin derived from medicinal homologous foods: its main signals in immunoregulation of oxidative stress, inflammation, and apoptosis, Front Immunol, 14
  122. Wang, 2018, Curcumin as a therapeutic agent for blocking NF-κb activation in ulcerative colitis, Immunopharmacol Immunotoxicol, 40, 476, 10.1080/08923973.2018.1469145 · DOI
  123. Jin, 2013, Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF-κb activation in gastric tissues of diabetic gastroparesis rats, Diabetol Metab Syndr, 5, 10.1186/1758-5996-5-12 · DOI
  124. Lin, 2021, Curcumin relieves mice gastric emptying dysfunction induced by L-arginine and atropine through interstitial cells of Cajal, Exp Ther Med, 21, 10.3892/etm.2021.9980 · DOI
  125. Zhang, 2014, Effects of curcumin on ion channels and transporters, Front Physiol, 5, 94, 10.3389/fphys.2014.00094 · DOI
  126. Singla, 2014, Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study, J Crohns Colitis, 8, 208, 10.1016/j.crohns.2013.08.006 · DOI
  127. Panda, 2022, A randomized, double-blind, placebo controlled, parallel-group, comparative clinical study to evaluate the efficacy and safety of OLNP-06 versus placebo in subjects with functional dyspepsia, J Diet Suppl, 19, 226, 10.1080/19390211.2020.1856996 · DOI
  128. Semwal, 2015, Gingerols and shogaols: important nutraceutical principles from ginger, Phytochemistry, 117, 554, 10.1016/j.phytochem.2015.07.012 · DOI · Paper page
  129. Cai, 2015, Effect of gingerol on colonic motility via inhibition of calcium channel currents in rats, World J Gastroenterol, 21, 13466, 10.3748/wjg.v21.i48.13466 · DOI
  130. Gwee, 2021, Herbal medicines in functional dyspepsia-untapped opportunities not without risks, Neurogastroenterol Motil, 33, 10.1111/nmo.14044 · DOI
  131. Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med, 64, 353, 10.1055/s-2006-957450 · DOI · Paper page
  132. Goerg, 2003, Effect of peppermint oil and caraway oil on gastrointestinal motility in healthy volunteers: a pharmacodynamic study using simultaneous determination of gastric and gall-bladder emptying and orocaecal transit time, Aliment Pharmacol Ther, 17, 445, 10.1046/j.1365-2036.2003.01421.x · DOI
  133. Madisch, 2004, Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial, Aliment Pharmacol Ther, 19, 271, 10.1111/j.1365-2036.2004.01859.x · DOI · Paper page
  134. Tominaga, 2015, Clinical application of kampo medicine (rikkunshito) for common and/or intractable symptoms of the gastrointestinal tract, Front Pharmacol, 6, 7, 10.3389/fphar.2015.00007 · DOI
  135. Lee, 2022, A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of DA-9701 (Motilitone) in patients with constipation-type irritable bowel syndrome and functional dyspepsia overlap: a pilot study, J Neurogastroenterol Motil, 28, 265, 10.5056/jnm20236 · DOI
  136. De Cicco, 2023, Chamomile essential oils exert anti-inflammatory effects involving human and murine macrophages: evidence to support a therapeutic action, J Ethnopharmacol, 311, 10.1016/j.jep.2023.116391 · DOI
  137. Wu, 2023, Licorice flavonoid alleviates gastric ulcers by producing changes in gut microbiota and promoting mucus cell regeneration, Biomed Pharmacother, 169, 10.1016/j.biopha.2023.115868 · DOI
  138. Aubert, 2019, Basal and spasmolytic effects of a hydroethanolic leaf extract of Melissa officinalis L. on intestinal motility: an ex vivo study, J Med Food, 22, 653, 10.1089/jmf.2018.0154 · DOI
  139. Madisch, 2001, A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study, Z Gastroenterol, 39, 511, 10.1055/s-2001-16142 · DOI
  140. Schemann, 2021, Effects of the herbal preparation STW 5-II on in vitro muscle activity in the guinea pig stomach, Neurogastroenterol Motil, 33, 10.1111/nmo.13984 · DOI · Paper page
  141. Rotondo, 2009, Gastric relaxation induced by apigenin and quercetin: analysis of the mechanism of action, Life Sci, 85, 85, 10.1016/j.lfs.2009.04.022 · DOI
  142. Yang, 2020, Luteolin suppresses colonic smooth muscle motility inhibiting L-type calcium channel currents in mice, Gen Physiol Biophys, 39, 49, 10.4149/gpb_2019045 · DOI · Paper page
  143. Mueller, 2009, A novel herbal preparation desensitizes mesenteric afferents to bradykinin in the rat small intestine, Neurogastroenterol Motil, 21, 467, 10.1111/j.1365-2982.2008.01232.x · DOI
  144. Mohammadi, 2022, STW 5-II is effective in reducing stress and postinflammatory induced visceral hypersensitivity in-vivo, Gastroenterology, 162, 10.1016/S0016-5085(22)60233-6 · DOI
  145. Elbadawi, 2021, Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids, Phytomedicine, 88, 10.1016/j.phymed.2021.153589 · DOI · Paper page
  146. Ammar, 2023, Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health, Phytomedicine, 119, 10.1016/j.phymed.2023.154996 · DOI · Paper page
  147. Tatsuta, 1993, Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients, Aliment Pharmacol Ther, 7, 459, 10.1111/j.1365-2036.1993.tb00120.x · DOI
  148. Tominaga, 2018, Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: a randomized clinical trial (the DREAM study), Neurogastroenterol Motil, 30, 10.1111/nmo.13319 · DOI
  149. Shih, 2019, The effect of xiang-sha-liu-jun-zi tang (XSLJZT) on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial, J Ethnopharmacol, 238, 10.1016/j.jep.2019.111889 · DOI · Paper page
  150. Matsumura, 2010, The traditional Japanese medicine rikkunshito increases the plasma level of ghrelin in humans and mice, J Gastroenterol, 45, 300, 10.1007/s00535-009-0166-z · DOI
  151. Tack, 2006, Influence of ghrelin on interdigestive gastrointestinal motility in humans, Gut, 55, 327, 10.1136/gut.2004.060426 · DOI
  152. Shiratori, 2011, Effect of rikkunshito on gastric sensorimotor function under distention, Neurogastroenterol Motil, 23, 323, 10.1111/j.1365-2982.2010.01648.x · DOI
  153. Tominaga, 2011, The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT(3) receptor pathway in rats, Evid Based Complement Altern Med, 2011, 10.1093/ecam/nep173 · DOI
  154. Kido, 2005, Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine, J Pharmacol Sci, 98, 161, 10.1254/jphs.FPJ04056X · DOI
  155. Kitagawa, 2015, Pharmacokinetic profiles of active ingredients and its metabolites derived from rikkunshito, a ghrelin enhancer, in healthy Japanese volunteers: a cross-over, randomized study, PLoS One, 10, 10.1371/journal.pone.0133159 · DOI
  156. Jang, 2013, Ghrelin receptor is activated by naringin and naringenin, constituents of a prokinetic agent, J Ethnopharmacol, 148, 459, 10.1016/j.jep.2013.04.039 · DOI
  157. Czigle, 2022, Treatment of gastrointestinal disorders-plants and potential mechanisms of action of their constituents, Molecules, 27
  158. Kwon, 2013, DA-9701: a new multi-acting drug for the treatment of functional dyspepsia, Biomol Ther, 21, 181, 10.4062/biomolther.2012.096 · DOI
  159. Jung, 2015, Pharmacokinetics and brain distribution of tetrahydropalmatine and tetrahydroberberine after oral administration of DA-9701, a new botanical gastroprokinetic agent, in rats, Biol Pharm Bull, 38, 285, 10.1248/bpb.b14-00678 · DOI
  160. Jin, 2018, DA-9701 (Motilitone): a multi-targeting botanical drug for the treatment of functional dyspepsia, Int J Mol Sci, 19, 10.3390/ijms19124035 · DOI
  161. Min, 2015, Effect of DA-9701 on gastric motor function assessed by magnetic resonance imaging in healthy volunteers: a randomized, double-blind, placebo-controlled trial, PLoS One, 10, 10.1371/journal.pone.0138927 · DOI
  162. Choi, 2015, Randomized, controlled, multi-center trial: comparing the safety and efficacy of DA-9701 and itopride hydrochloride in patients with functional dyspepsia, J Neurogastroenterol Motil, 21, 414, 10.5056/jnm14117 · DOI
  163. Kim, 2014, Effect of DA-9701 on colorectal distension-induced visceral hypersensitivity in a rat model, Gut Liver, 8, 388, 10.5009/gnl.2014.8.4.388 · DOI
  164. Lee, 2008, Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with pharbitis semen and corydalis tuber, Phytomedicine, 15, 836, 10.1016/j.phymed.2008.02.019 · DOI
  165. Lim, 2013, Effect of DA-9701 on gastric emptying in a mouse model: assessment by (1)(3)C-octanoic acid breath test, World J Gastroenterol, 19, 4380, 10.3748/wjg.v19.i27.4380 · DOI
  166. Lee, 2010, Effects of corydaline from Corydalis tuber on gastric motor function in an animal model, Biol Pharm Bull, 33, 958, 10.1248/bpb.33.958 · DOI
  167. Lee, 2011, Tetrahydroberberine, an isoquinoline alkaloid isolated from corydalis tuber, enhances gastrointestinal motor function, J Pharmacol Exp Ther, 338, 917, 10.1124/jpet.111.182048 · DOI
  168. Xiao, 2022, Zhizhu Kuanzhong, a traditional Chinese medicine, alleviates gastric hypersensitivity and motor dysfunction on a rat model of functional dyspepsia, Front Pharmacol, 13, 10.3389/fphar.2022.1026660 · DOI
  169. Xiao, 2022, Zhizhu Kuanzhong Capsule in treating patients with functional dyspepsia postprandial distress syndrome: study protocol for a multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial, Trials, 23, 454, 10.1186/s13063-022-06396-5 · DOI
  170. Xiao, 2019, The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome, J Gastroenterol Hepatol, 34, 526, 10.1111/jgh.14467 · DOI
  171. Wang, 2023, Stigma and efficacy of Zhizhu Kuanzhong capsules versus doxepin in the treatment of refractory functional dyspepsia: a randomized controlled trial, J Neurogastroenterol Motil, 29, 360, 10.5056/jnm22145 · DOI
  172. Karimzadeh, 2021, The effects of lavender and citrus aurantium on anxiety and agitation of the conscious patients in intensive care units: a parallel randomized placebo-controlled trial, Biomed Res Int, 2021, 10.1155/2021/5565956 · DOI
  173. Li, 2022, Proprietary medicines containing bupleurum chinense DC. (Chaihu) for depression: network meta-analysis and network pharmacology prediction, Front Pharmacol, 13
  174. Jiang, 2014, The effects of fructus aurantii extract on the 5-hydroxytryptamine and vasoactive intestinal peptide contents of the rat gastrointestinal tract, Pharm Biol, 52, 581, 10.3109/13880209.2013.854396 · DOI
  175. Wang, 2014, The metabolism of polysaccharide from atractylodes macrocephala koidz and its effect on intestinal microflora, Evid Based Complement Altern Med, 10.1155/2014/926381 · DOI
  176. Efferth, 2011, Toxicities by herbal medicines with emphasis to traditional Chinese medicine, Curr Drug Metab, 12, 989, 10.2174/138920011798062328 · DOI
  177. Wang, 2023, Advancing herbal medicine: enhancing product quality and safety through robust quality control practices, Front Pharmacol, 14
  178. Zhang, 2021, Comparison of the guidelines on good agricultural and collection practices in herbal medicine of the European Union, China, the WHO, and the United States of America, Pharmacol Res, 167, 10.1016/j.phrs.2021.105533 · DOI
  179. Arlt, 2002, Aristolochic acid as a probable human cancer hazard in herbal remedies: a review, Mutagenesis, 17, 265, 10.1093/mutage/17.4.265 · DOI
  180. Sarwat, 2016, DNA barcoding, microarrays and next generation sequencing: recent tools for genetic diversity estimation and authentication of medicinal plants, Crit Rev Biotechnol, 36, 191, 10.3109/07388551.2014.947563 · DOI
  181. Wolfender, 2013, Plant metabolomics: from holistic data to relevant biomarkers, Curr Med Chem, 20, 1056
  182. Srirama, 2017, Species adulteration in the herbal trade: causes, consequences and mitigation, Drug Saf, 40, 651, 10.1007/s40264-017-0527-0 · DOI

Cited by

Metadata

Authors
Moniruzzaman, M., Shah, A., Morrison, M., Koloski, N., Gwee, K. A., Chen, M., Kim, Y., Ayaki, K., Efferth, T., & Holtmann, G.
ORCID
Venue
Digestive and Liver Disease
Publisher
Elsevier BV
Published
2025-09
Volume
57
Issue
9
Pages
1717-1729
ISSN
1590-8658
DOI
10.1016/j.dld.2025.07.010
Cited by
8
References
8
Language
en
Licence
Funders
National Health and Medical Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.